Ingredients

SARS rearing its head again?

SARS rearing its head again?

There are fears that a renewed epidemic of severe acute respiratory
syndrome (SARS) could occur in 2004, after initial tests on a
patient with symptoms associated with the disease suggested that
the causative agent was the SARS coronavirus...

Haplotype team unveil goals

Haplotype team unveil goals

The international team of scientists working to determine the most
common variations of the human genome have given more details of
the rationale behind the effort, known as the HapMap project, in
the journal Nature (18 December).

Major deal for TransForm

Major deal for TransForm

Formulation specialist TransForm Pharmaceuticals has licensed a
novel salt form of the antiepileptic drug topiramate to Johnson
& Johnson in a development that provides the first real
validation of its business model.

Degussa lauded by F&S

Degussa lauded by F&S

Germany's third-largest chemicals company Degussa has won the Frost
& Sullivan Product of the Year Award for its L-hydantoinase
enzymatic process for single-step production of L-amino acids, used
in the pharmaceutical, food...

NME approvals on the rise?

NME approvals on the rise?

The US Food and Drug Administration (FDA) approved 15 New Molecular
Entities in the current year to 30 September, 2003, setting the
stage to outpace last year's registrations by nearly 20 per cent,
says a report from Cutting...

Boom time for CROs?

Boom time for CROs?

The amount of pharmaceutical R&D funding headed out-of-house to
research suppliers engaged in drug development work will grow
almost 15 per cent annually for the next five years, nearly double
the anticipated increase in overall...

Making waves in proteomics

Making waves in proteomics

It is already well established that microwave energy can be used to
speed up the breakdown of protein molecules by enzymes, the first
stage in protein identification. Now, a collaboration between two
companies is looking to incorporate...

Digital chemistry

Digital chemistry

Determining the molecular structure of drugs is one of the
foundations of the discovery and development of new medicines and
underpins the synthesis of novel drugs. But will the new generation
of computer-based models for this supplant...

Follow us

Products

View more

Webinars